| BML-PW0765-0025 | 25 µl | 90.00 USD | ![]() |
||
| BML-PW0765-0100 | 100 µl | 312.00 USD | ![]() |
||
| Concentration: | 1mg/ml |
| Purity Detail: | Protein G-affinity purified. |
| Purity: | ≥95% (SDS-PAGE). |
| Formulation: | Liquid. In PBS containing 0.01% sodium azide. |
| Clone: | 4F1 |
| Isotype: | Mouse IgG2a. |
| Immunogen: | Recombinant human FAT10. |
| Source/Host: | From mouse. Purified from hybridoma tissue culture supernatant. |
| Specificity: | Recognizes human FAT10. |
| Application: | Immunocytochemistry: recommended initial dilution at least (1:100). |
| Short Term Storage: | +4°C |
| Long Term Storage: | -20°C |
| Use/Stability: | Stable for at least 1 year after receipt when stored at -20°C. Store diluted antibody at 2-4°C and use within 1 month. |
| Handling: | After opening, prepare aliquots and store at -20°C. Avoid freeze/thaw cycles. |
| Miscellaneous/General: | FAT10 is a ubiquitin-like protein (UBL), that is encoded in the major histocompatibility complex class I locus and is synergistically inducible with IFN-α and TNF-α. It is composed of two ubiquitin-like domains and possesses a free C-terminal diglycine motif that is required for FAT10 conjugate formation. Conjugation with FAT10 provides an alternative, cytokine inducible, ubiquitin-independent targeting mechanism for protein degradation by the proteasome, mediated by factors such as NUB1L. Although its function has not been fully elucidated, FAT10 has been shown to play important roles in various cellular processes including cell cycle control, chromosomal stability and apoptosis, and its up-regulation has been observed in various forms of cancer and HIV-associated renal disease. FAT10 expression is negatively regulated by the p53 tumour suppressor protein. |
| Background / Technical Information: | The hybridoma secreting the antibody 4F1 was generated by fusion of splenocytes from FAT10-/- mice which had received repeated immunisation with recombinant human GST-FAT10 (accession number: O15205). ELISA was used to exclude hybridomas producing antibodies with anti-GST activity and the 4F1 clone was stabilised after subsequent rounds of subcloning. The antibody was purified from cell culture supernatant using protein G agarose affinity chromatography. The antibody has been characterized by Western blotting against HA-FAT10 transfected and TNF-α/IFN-γ treated HEK293T cell lysates, by immunofluorescence utilizing HA-FAT10 transfected HEK293T cells, and by Immunoprecipitation. UniProt ID: O15205: FAT10 (human) |
